Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -20.30M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 100
Avg Vol 99,308
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 62%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with...

Industry: Biotechnology
Sector: Healthcare
Phone: 604-921-1810
Fax: 604-921-1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
Latest News on BCTXW
No data available.